The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Analysis of primary and acquired resistance to cetuximab from multiomic data in the New EPOC trial.
 
Sian Alexandra Pugh
Honoraria - Merck; SERVIER
 
Enric Domingo
No Relationships to Disclose
 
Susan D Richman
No Relationships to Disclose
 
Philip D Dunne
No Relationships to Disclose
 
Keara Redmond
No Relationships to Disclose
 
Andrew Blake
No Relationships to Disclose
 
Zina Eminton
No Relationships to Disclose
 
Ian Tomlinson
No Relationships to Disclose
 
Timothy S. Maughan
Consulting or Advisory Role - AstraZeneca/MedImmune; Ground Truth Laboratories; Nordic Bioscience; Nordic Bioscience; Perspectum Diagnostics
Research Funding - Almac Diagnostics (Inst); AstraZeneca (Inst); Merck KgAA (Inst); PsiOxus Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - patent pending
 
John Neil Primrose
Honoraria - AstraZeneca
 
John A Bridgewater
Honoraria - Incyte; SERVIER
Consulting or Advisory Role - AstraZeneca; Basilea; Bayer; Incyte; Merck Serono; Merck Serono; Roche; SERVIER; Taiho Oncology
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene
Research Funding - Amgen; Incyte (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Bristol-Myers Squibb/Medarex; Merck Serono; MSD Oncology; SERVIER